[Brain radionecrosis in patients irradiated for nasopharyngeal carcinoma: about nine cases]
- PMID: 17631405
- DOI: 10.1016/j.canrad.2007.04.001
[Brain radionecrosis in patients irradiated for nasopharyngeal carcinoma: about nine cases]
Abstract
Purpose: To study the clinical, radiological, therapeutic and progressive aspects of brain radionecrosis after treatment for nasopharyngeal carcinoma.
Patients and methods: Nine patients (seven men and two women) of mean age 47.7 years old (extremes: 18-57 years old) were treated for UCNT (undifferentiated carcinoma of the nasopharynx) between 1989 and 2003 and developed cerebral radionecrosis. All patients were treated with radical radiotherapy. The mean total dose was 73.5 Gy (70-75 Gy). Dose per fraction was 2 to 2.5 Gy, one fraction daily. One patient received adjuvant brachytherapy to the dose of 8 Gy and four patients also received chemotherapy.
Results: Brain radionecrosis was authenticated by brain imaging (CT scan+/-MRI): the imaging was ordered in seven cases to elucidate non-specific neurological signs and two cases were discovered fortuitously. The time to the appearance of neurological signs was 40.3 months (10 to 108 months). The localization was temporal in six cases, parieto-occipital (one case) and bulbomedullar (two cases). After a mean follow-up period of 30.6 months (12-84 months), clinical outcomes were favorable in all cases receiving medical treatment (corticoids), with a stabilization of the radiological lesions in eight cases and complete radiological regression in one patient.
Conclusion: Brain radionecrosis is a late complication rarely occurring in patients irradiated for UCNT. Imaging techniques (CT scan but more so MRI) play a major role in the diagnosis. Corticotherapy resulted in a durable objective response in all patients and, in most cases, resulted in radiological stabilization.
Similar articles
-
[CT and MRI aspects of 28 patients with cerebral radiation necrosis irradiated for ORL tumors: correlation with the radiation technique].J Radiol. 2002 Nov;83(11):1749-57. J Radiol. 2002. PMID: 12469012 French.
-
Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.Head Neck. 2004 May;26(5):389-95. doi: 10.1002/hed.10398. Head Neck. 2004. PMID: 15122654 Clinical Trial.
-
Cerebral radionecrosis in patients with nasopharyngeal carcinoma.Kaohsiung J Med Sci. 2005 Oct;21(10):452-9. doi: 10.1016/S1607-551X(09)70150-0. Kaohsiung J Med Sci. 2005. PMID: 16302448 Free PMC article.
-
Factors affecting risk of symptomatic temporal lobe necrosis: significance of fractional dose and treatment time.Int J Radiat Oncol Biol Phys. 2002 May 1;53(1):75-85. doi: 10.1016/s0360-3016(02)02711-6. Int J Radiat Oncol Biol Phys. 2002. PMID: 12007944 Review.
-
[Carcinoma of the nasopharynx. Clinical aspects, indications and results of external radiotherapy and brachytherapy. State of the art in 2001].Cancer Radiother. 2001 Nov;5 Suppl 1:189s-194s. Cancer Radiother. 2001. PMID: 11797281 Review. French.
Cited by
-
[Cerebral radiation necrosis in patients irradiated for nasopharyngeal cancer: report of 3 cases].Pan Afr Med J. 2014 Sep 30;19:111. doi: 10.11604/pamj.2014.19.111.5361. eCollection 2014. Pan Afr Med J. 2014. PMID: 25722784 Free PMC article. French.
-
[Management of cerebral radionecrosis: experience in the Department of Neurology at the Mohammed V Military Teaching Hospital].Pan Afr Med J. 2019 Jul 11;33:188. doi: 10.11604/pamj.2019.33.188.19325. eCollection 2019. Pan Afr Med J. 2019. PMID: 31692728 Free PMC article. French.
-
Radionecrosis of the frontal lobe as a consequence of malignant ethmoid tumor management: incidence, diagnosis, risk factors, prevention and management.Eur Arch Otorhinolaryngol. 2014 Dec;271(12):3223-32. doi: 10.1007/s00405-014-3013-7. Epub 2014 Apr 16. Eur Arch Otorhinolaryngol. 2014. PMID: 24737053
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical